Zoetis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. 

CEO
Kristin C. Peck
CEOKristin C. Peck
Employees
14,500
Employees14,500
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1952
Founded1952
Employees
14,500
Employees14,500

ZTS Key Statistics

Market cap
47.33B
Market cap47.33B
Price-Earnings ratio
18.69
Price-Earnings ratio18.69
Dividend yield
1.83%
Dividend yield1.83%
Average volume
3.58M
Average volume3.58M
High today
$113.51
High today$113.51
Low today
$111.27
Low today$111.27
Open price
$112.67
Open price$112.67
Volume
3.36M
Volume3.36M
52 Week high
$172.23
52 Week high$172.23
52 Week low
$111.27
52 Week low$111.27

Stock Snapshot

Zoetis(ZTS) stock is priced at $112.54, giving the company a market capitalization of 47.33B. It carries a P/E multiple of 18.69 and pays a dividend yield of 1.8%.

On 2026-05-06, Zoetis(ZTS) stock traded between a low of $111.27 and a high of $113.51. Shares are currently priced at $112.54, which is +1.1% above the low and -0.9% below the high.

The Zoetis(ZTS)'s current trading volume is 3.36M, compared to an average daily volume of 3.58M.

During the past year, Zoetis(ZTS) stock moved between $111.27 at its lowest and $172.23 at its peak.

During the past year, Zoetis(ZTS) stock moved between $111.27 at its lowest and $172.23 at its peak.

ZTS News

Simply Wall St 3d
Is Zoetis’ OptiCell Upgrade Quietly Rebalancing Its Innovation And Recurring Revenue Mix?

Zoetis recently expanded the capabilities of its AI-powered Vetscan OptiCell hematology analyzer, while investors and analysts have turned their attention to it...

Is Zoetis’ OptiCell Upgrade Quietly Rebalancing Its Innovation And Recurring Revenue Mix?
Simply Wall St 6d
Is Zoetis Now An Opportunity After A 31% Five Year Share Price Drop

If you have been wondering whether Zoetis at around US$113.83 is starting to look attractively priced, you are not alone. The stock has seen a 3.1% decline ove...

Is Zoetis Now An Opportunity After A 31% Five Year Share Price Drop

Analyst ratings

65%

of 23 ratings
Buy
65.2%
Hold
34.8%
Sell
0%

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.